Standard Biotools (LAB) Acquisitions (2014 - 2024)

Standard Biotools (LAB) reported Acquisitions of -$278.6 million for Q4 2024, down 199.51% quarter-over-quarter from $280.0 million in Q1 2024.

Standard Biotools (LAB) Acquisitions (2014 - 2024) Analysis & Trends

Standard Biotools (LAB) has 3 years of Acquisitions data on file, last reported at -$278.6 million in Q4 2024.

Acquisitions for Q4 2024 came in at -$278.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $1.4 million (changed N/A YoY), and the FY2024 annual result was $1.4 million, changed N/A from the prior year.
Acquisitions declined to -$278.6 million in Q4 2024 per LAB's latest filing, from $280.0 million in the prior quarter.
Over five years, Acquisitions peaked at $280.0 million in Q1 2024 and troughed at -$278.6 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	22.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-268.10 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.30 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Standard Biotools	319.06 Mn	-136.11 Mn	11.31 Mn	-

Download Data